Cite

HARVARD Citation

    Jane Lim-Fat, M. et al. (n.d.). PATH-03. CLINICAL UTILITY OF NEXT GENERATION SEQUENCING IN IDH-WILDTYPE GLIOBLASTOMA: THE DANA-FARBER CANCER INSTITUTE EXPERIENCE. Neuro-oncology. p. ii164. [Online]. 
  
Back to record